% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schimunek:1037884,
author = {Schimunek, Johannes and Seidl, Philipp and Elez, Katarina
and Hempel, Tim and Le, Tuan and Noé, Frank and Olsson,
Simon and Raich, Lluís and Winter, Robin and Gokcan, Hatice
and Gusev, Filipp and Gutkin, Evgeny M. and Isayev, Olexandr
and Kurnikova, Maria G. and Narangoda, Chamali H. and
Zubatyuk, Roman and Bosko, Ivan P. and Furs, Konstantin V.
and Karpenko, Anna D. and Kornoushenko, Yury V. and Shuldau,
Mikita and Yushkevich, Artsemi and Benabderrahmane, Mohammed
B. and Bousquet-Melou, Patrick and Bureau, Ronan and
Charton, Beatrice and Cirou, Bertrand C. and Gil, Gérard
and Allen, William J. and Sirimulla, Suman and Watowich,
Stanley and Antonopoulos, Nick A. and Epitropakis, Nikolaos
E. and Krasoulis, Agamemnon K. and Pitsikalis, Vassilis P.
and Theodorakis, Stavros T. and Kozlovskii, Igor and
Maliutin, Anton and Medvedev, Alexander and Popov, Petr and
Zaretckii, Mark and Eghbal-zadeh, Hamid and Halmich,
Christina and Hochreiter, Sepp and Mayr, Andreas and Ruch,
Peter and Widrich, Michael and Berenger, Francois and Kumar,
Ashutosh and Yamanishi, Yoshihiro and Zhang, Kam Y. J. and
Bengio, Emmanuel and Bengio, Yoshua and Jain, Moksh J. and
Korablyov, Maksym and Liu, Cheng-Hao and Marcou, Gilles and
Glaab, Enrico and Barnsley, Kelly and Iyengar, Suhasini M.
and Ondrechen, Mary Jo and Haupt, V. Joachim and Kaiser,
Florian and Schroeder, Michael and Pugliese, Luisa and
Albani, Simone and Athanasiou, Christina and Beccari, Andrea
and Carloni, Paolo and D'Arrigo, Giulia and Gianquinto,
Eleonora and Goßen, Jonas and Hanke, Anton and Joseph,
Benjamin P. and Kokh, Daria B. and Kovachka, Sandra and
Manelfi, Candida and Mukherjee, Goutam and Muñiz-Chicharro,
Abraham and Musiani, Francesco and Nunes-Alves, Ariane and
Paiardi, Giulia and Rossetti, Giulia and Sadiq, S. Kashif
and Spyrakis, Francesca and Talarico, Carmine and Tsengenes,
Alexandros and Wade, Rebecca C. and Copeland, Conner and
Gaiser, Jeremiah and Olson, Daniel R. and Roy, Amitava and
Venkatraman, Vishwesh and Wheeler, Travis J. and Arthanari,
Haribabu and Blaschitz, Klara and Cespugli, Marco and
Durmaz, Vedat and Fackeldey, Konstantin and Fischer, Patrick
D. and Gorgulla, Christoph and Gruber, Christian and Gruber,
Karl and Hetmann, Michael and Kinney, Jamie E. and
Padmanabha Das, Krishna M. and Pandita, Shreya and Singh,
Amit and Steinkellner, Georg and Tesseyre, Guilhem and
Wagner, Gerhard and Wang, Zi-Fu and Yust, Ryan J. and
Druzhilovskiy, Dmitry S. and Filimonov, Dmitry A. and
Pogodin, Pavel V. and Poroikov, Vladimir and Rudik,
Anastassia V. and Stolbov, Leonid A. and Veselovsky,
Alexander V. and De Rosa, Maria and De Simone, Giada and
Gulotta, Maria R. and Lombino, Jessica and Mekni, Nedra and
Perricone, Ugo and Casini, Arturo and Embree, Amanda and
Gordon, D. Benjamin and Lei, David and Pratt, Katelin and
Voigt, Christopher A. and Chen, Kuang-Yu and Jacob, Yves and
Krischuns, Tim and Lafaye, Pierre and Zettor, Agnès and
Rodríguez, M. Luis and White, Kris M. and Fearon, Daren and
Von Delft, Frank and Walsh, Martin A. and Horvath, Dragos
and Brooks III, Charles L. and Falsafi, Babak and Ford,
Bryan and García-Sastre, Adolfo and Lee, Sang Yup and
Naffakh, Nadia and Varnek, Alexandre and Klambauer, Günter
and Hermans, Thomas M.},
title = {{A} community effort to discover small molecule
{SARS}-{C}o{V}-2 inhibitors},
journal = {Molecular informatics},
volume = {43},
number = {1},
issn = {1868-1743},
address = {Weinheim},
publisher = {Wiley-VCH-Verl.},
reportid = {FZJ-2025-01027},
pages = {e202300262},
year = {2024},
abstract = {The COVID-19 pandemic continues to pose a substantial
threat to human lives and is likely to do so for years to
come. Despite the availability of vaccines, searching for
efficient small-molecule drugs that are widely available,
including in low- and middle-income countries, is an ongoing
challenge. In this work, we report the results of an open
science community effort, the “Billion molecules against
COVID-19 challenge”, to identify small-molecule inhibitors
against SARS-CoV-2 or relevant human receptors.
Participating teams used a wide variety of computational
methods to screen a minimum of 1 billion virtual molecules
against 6 protein targets. Overall, 31 teams participated,
and they suggested a total of 639,024 molecules, which were
subsequently ranked to find ‘consensus compounds’. The
organizing team coordinated with various contract research
organizations (CROs) and collaborating institutions to
synthesize and test 878 compounds for biological activity
against proteases (Nsp5, Nsp3, TMPRSS2), nucleocapsid N,
RdRP (only the Nsp12 domain), and (alpha) spike protein S.
Overall, 27 compounds with weak inhibition/binding were
experimentally identified by binding-, cleavage-, and/or
viral suppression assays and are presented here. Open
science approaches such as the one presented here contribute
to the knowledge base of future drug discovery efforts in
finding better SARS-CoV-2 treatments.},
cin = {INM-9},
ddc = {530},
cid = {I:(DE-Juel1)INM-9-20140121},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {37833243},
UT = {WOS:001100903100001},
doi = {10.1002/minf.202300262},
url = {https://juser.fz-juelich.de/record/1037884},
}